OBJECTIVE: To evaluate the outcomes observed with pelvic exenteration with curative intent for recurrent uterine @entity5 in the modern era. METHODS: We reviewed the records of all @entity1 who underwent this procedure at our institution between 1/1997 and 03/2011. @entity260 up to 90 days after surgery were analyzed and graded as per our institution grading system. Survivals were estimated using the Kaplan-Meier method. RESULTS: During the study period, 21 @entity1 were identified. Median age at the time of exenteration was 57 years (range, 36-75). Median @entity5 size was 6 cm (range, microscopic - 14.5). @entity5 histology was: endometrioid, 10 cases; mixed, serous, and @entity6962 , 7 cases; and @entity242 , 4 cases. The type of exenteration was: total, 14 cases; anterior, 6 cases and posterior, 1 case. There were no intra- or postoperative mortalities. Seven @entity1 (33%) developed at least one grade 2 complication, and 10 @entity1 (48%) developed at least one grade 3 complication. Five (24%) @entity1 had to be re-operated on in the first 90 days post surgery. The median follow up time after exenteration was 39 months (range, 5-112). The 5-year survival of the entire cohort was 40% (95% CI: 18-63). An improved survival was observed in @entity1 with @entity5 and @entity242 (5-year survival rates of 50% and 66%, respectively). The presence of pelvic sidewall involvement and/or @entity3041 did not negatively affect survival. CONCLUSION: Pelvic exenteration for recurrent uterine @entity5 can be associated with long-term survival in properly selected @entity1 . A high rate of @entity260 remains a hallmark of this procedure and should be discussed carefully with @entity1 facing this decision.

Pelvic exenteration with curative intent for recurrent uterine XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity242 :: ('MESH:D012509', 'Disease') :: ['sarcomas'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'endometrioid tumors', 'Tumor', 'malignancies'] @entity260 :: ('MESH:D011183', 'Disease') :: ['Postoperative complications', 'postoperative complications'] @entity3041 :: ('MESH:D006869', 'Disease') :: ['hydronephrosis'] @entity6962 :: ('MESH:D002296', 'Disease') :: ['carcinosarcoma']
@entity5 :: (MESH:D009369,Disease) :: ['malignancies']
